US Stock MarketDetailed Quotes

AQST Aquestive Therapeutics

Watchlist

3.290
+0.205+6.65%

Close May 9 16:00 ET

3.390
+0.100+3.04%

Post 18:37 ET

299.52MMarket Cap-8024P/E (TTM)

Aquestive Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

6.09%50.58M

23.63%13.21M

13.43%13M

-0.18%13.24M

-9.26%11.13M

-6.20%47.68M

-3.57%10.68M

-13.73%11.46M

-13.55%13.27M

10.32%12.27M

Operating revenue

6.09%50.58M

23.63%13.21M

13.43%13M

-0.18%13.24M

-9.26%11.13M

-6.20%47.68M

-3.57%10.68M

-13.73%11.46M

-13.55%13.27M

10.32%12.27M

Cost of revenue

7.45%20.83M

-11.80%4.68M

3.74%4.8M

26.23%6.62M

12.41%4.74M

29.33%19.39M

57.61%5.31M

5.11%4.63M

17.38%5.24M

52.85%4.21M

Gross profit

5.15%29.75M

58.58%8.53M

19.98%8.2M

-17.44%6.62M

-20.59%6.4M

-21.06%28.29M

-30.28%5.38M

-23.06%6.84M

-26.25%8.02M

-3.69%8.06M

Operating expense

-36.25%44.85M

-22.70%12.44M

-32.57%10.58M

-47.88%10.83M

-38.17%11M

-0.23%70.36M

-16.98%16.09M

-6.91%15.69M

19.48%20.79M

5.35%17.79M

Selling and administrative expenses

-39.96%31.75M

-19.15%9.55M

-40.73%7.39M

-52.78%7.36M

-42.75%7.46M

-1.11%52.88M

-21.15%11.81M

2.72%12.46M

18.68%15.59M

-1.59%13.02M

Research and development costs

-25.04%13.1M

-32.49%2.89M

-1.11%3.2M

-33.19%3.47M

-25.69%3.55M

2.55%17.48M

-2.77%4.28M

-31.61%3.23M

21.96%5.2M

30.45%4.77M

Operating profit

64.10%-15.1M

63.49%-3.91M

73.15%-2.38M

67.02%-4.21M

52.71%-4.61M

-21.30%-42.07M

8.19%-10.71M

-11.11%-8.85M

-95.83%-12.76M

-14.23%-9.74M

Net non-operating interest income expense

171.77%8.86M

-87.31%-3.07M

105.48%202K

63.31%-1.3M

474.10%13.03M

43.99%-12.34M

52.55%-1.64M

44.09%-3.68M

39.49%-3.54M

43.35%-3.48M

Non-operating interest income

16,385.86%16.32M

153.85%165K

30,180.00%1.51M

303.13%129K

--14.51M

-76.60%99K

-51.85%65K

--5K

-91.42%32K

----

Non-operating interest expense

-40.03%7.46M

89.85%3.24M

-64.43%1.31M

-60.02%1.43M

-57.29%1.49M

-44.60%12.44M

-52.52%1.7M

-44.01%3.69M

-42.60%3.57M

-43.35%3.48M

Other net income (expense)

-1.38M

-1.03M

-353K

Special income (charges)

---1.38M

---1.03M

--0

---353K

--0

-Less:Other special charges

--1.38M

--1.03M

----

--353K

----

Income before tax

85.99%-7.63M

35.15%-8.01M

82.65%-2.18M

66.21%-5.51M

161.03%8.07M

22.87%-54.41M

57.33%-12.35M

13.87%-12.54M

-31.82%-16.3M

9.90%-13.22M

Income tax

245K

101K

-140K

284K

Net income

85.54%-7.87M

34.33%-8.11M

83.77%-2.04M

64.47%-5.79M

161.03%8.07M

22.87%-54.41M

57.33%-12.35M

13.87%-12.54M

-31.82%-16.3M

9.90%-13.22M

Net income continuous Operations

85.54%-7.87M

34.33%-8.11M

83.77%-2.04M

64.47%-5.79M

161.03%8.07M

22.87%-54.41M

57.33%-12.35M

13.87%-12.54M

-31.82%-16.3M

9.90%-13.22M

Minority interest income

Net income attributable to the parent company

85.54%-7.87M

34.33%-8.11M

83.77%-2.04M

64.47%-5.79M

161.03%8.07M

22.87%-54.41M

57.33%-12.35M

13.87%-12.54M

-31.82%-16.3M

9.90%-13.22M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

85.54%-7.87M

34.33%-8.11M

83.77%-2.04M

64.47%-5.79M

161.03%8.07M

22.87%-54.41M

57.33%-12.35M

13.87%-12.54M

-31.82%-16.3M

9.90%-13.22M

Basic earnings per share

88.39%-0.13

41.71%-0.1341

86.96%-0.03

72.22%-0.1

146.88%0.15

39.46%-1.12

68.06%-0.23

37.84%-0.23

-9.09%-0.36

21.95%-0.32

Diluted earnings per share

88.39%-0.13

41.71%-0.1341

86.96%-0.03

72.22%-0.1

134.38%0.11

39.46%-1.12

68.06%-0.23

37.84%-0.23

-9.09%-0.36

21.95%-0.32

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	6.09%50.58M	23.63%13.21M	13.43%13M	-0.18%13.24M	-9.26%11.13M	-6.20%47.68M	-3.57%10.68M	-13.73%11.46M	-13.55%13.27M	10.32%12.27M
Operating revenue	6.09%50.58M	23.63%13.21M	13.43%13M	-0.18%13.24M	-9.26%11.13M	-6.20%47.68M	-3.57%10.68M	-13.73%11.46M	-13.55%13.27M	10.32%12.27M
Cost of revenue	7.45%20.83M	-11.80%4.68M	3.74%4.8M	26.23%6.62M	12.41%4.74M	29.33%19.39M	57.61%5.31M	5.11%4.63M	17.38%5.24M	52.85%4.21M
Gross profit	5.15%29.75M	58.58%8.53M	19.98%8.2M	-17.44%6.62M	-20.59%6.4M	-21.06%28.29M	-30.28%5.38M	-23.06%6.84M	-26.25%8.02M	-3.69%8.06M
Operating expense	-36.25%44.85M	-22.70%12.44M	-32.57%10.58M	-47.88%10.83M	-38.17%11M	-0.23%70.36M	-16.98%16.09M	-6.91%15.69M	19.48%20.79M	5.35%17.79M
Selling and administrative expenses	-39.96%31.75M	-19.15%9.55M	-40.73%7.39M	-52.78%7.36M	-42.75%7.46M	-1.11%52.88M	-21.15%11.81M	2.72%12.46M	18.68%15.59M	-1.59%13.02M
Research and development costs	-25.04%13.1M	-32.49%2.89M	-1.11%3.2M	-33.19%3.47M	-25.69%3.55M	2.55%17.48M	-2.77%4.28M	-31.61%3.23M	21.96%5.2M	30.45%4.77M
Operating profit	64.10%-15.1M	63.49%-3.91M	73.15%-2.38M	67.02%-4.21M	52.71%-4.61M	-21.30%-42.07M	8.19%-10.71M	-11.11%-8.85M	-95.83%-12.76M	-14.23%-9.74M
Net non-operating interest income expense	171.77%8.86M	-87.31%-3.07M	105.48%202K	63.31%-1.3M	474.10%13.03M	43.99%-12.34M	52.55%-1.64M	44.09%-3.68M	39.49%-3.54M	43.35%-3.48M
Non-operating interest income	16,385.86%16.32M	153.85%165K	30,180.00%1.51M	303.13%129K	--14.51M	-76.60%99K	-51.85%65K	--5K	-91.42%32K	----
Non-operating interest expense	-40.03%7.46M	89.85%3.24M	-64.43%1.31M	-60.02%1.43M	-57.29%1.49M	-44.60%12.44M	-52.52%1.7M	-44.01%3.69M	-42.60%3.57M	-43.35%3.48M
Other net income (expense)	-1.38M	-1.03M			-353K
Special income (charges)	---1.38M	---1.03M	--0	--0	---353K	--0	--0	--0	--0	--0
-Less:Other special charges	--1.38M	--1.03M	----	----	--353K	----	----	----	----	----
Income before tax	85.99%-7.63M	35.15%-8.01M	82.65%-2.18M	66.21%-5.51M	161.03%8.07M	22.87%-54.41M	57.33%-12.35M	13.87%-12.54M	-31.82%-16.3M	9.90%-13.22M
Income tax	245K	101K	-140K	284K	0	0	0	0	0	0
Net income	85.54%-7.87M	34.33%-8.11M	83.77%-2.04M	64.47%-5.79M	161.03%8.07M	22.87%-54.41M	57.33%-12.35M	13.87%-12.54M	-31.82%-16.3M	9.90%-13.22M
Net income continuous Operations	85.54%-7.87M	34.33%-8.11M	83.77%-2.04M	64.47%-5.79M	161.03%8.07M	22.87%-54.41M	57.33%-12.35M	13.87%-12.54M	-31.82%-16.3M	9.90%-13.22M
Minority interest income
Net income attributable to the parent company	85.54%-7.87M	34.33%-8.11M	83.77%-2.04M	64.47%-5.79M	161.03%8.07M	22.87%-54.41M	57.33%-12.35M	13.87%-12.54M	-31.82%-16.3M	9.90%-13.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	85.54%-7.87M	34.33%-8.11M	83.77%-2.04M	64.47%-5.79M	161.03%8.07M	22.87%-54.41M	57.33%-12.35M	13.87%-12.54M	-31.82%-16.3M	9.90%-13.22M
Basic earnings per share	88.39%-0.13	41.71%-0.1341	86.96%-0.03	72.22%-0.1	146.88%0.15	39.46%-1.12	68.06%-0.23	37.84%-0.23	-9.09%-0.36	21.95%-0.32
Diluted earnings per share	88.39%-0.13	41.71%-0.1341	86.96%-0.03	72.22%-0.1	134.38%0.11	39.46%-1.12	68.06%-0.23	37.84%-0.23	-9.09%-0.36	21.95%-0.32
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall